Interleukin-8 (IL-8), a potent inflammatory mediator that is thought t
o control leukocyte recruitment and activation during inflammatory rea
ctions, has been implicated in a variety of inflammatory diseases. Rec
ent studies in our laboratory have demonstrated the presence of IL-8 i
n chronically inflamed human middle ear effusions. These data have led
us to hypothesize that IL-8 is responsible for the leukocyte recruitm
ent seen in otitis media. Because the effect of IL-8 on the middle ear
mucosa has not been investigated and therefore its role in middle ear
inflammation is not known, we investigated the ability of IL-8 to dir
ectly induce inflammation in the murine middle ear. For these studies,
ICR mice were used to test the hypothesis that IL-8 could directly in
duce inflammation in the middle ear. Murine middle ears received 8-mL
transtympanic injections of human IL-8 (25 mg/mL) in saline, heat-kill
ed Streptococcus pneumoniae (1 x 10(8)/mL), or normal saline. Temporal
bones were removed at 1, 4, 8, 24, and 48 hours, decalcified, and pro
cessed for histologic examination. Noninjected murine temporal bones s
erved as controls. Normal saline-injected ears demonstrated little to
no change as compared with temporal bones from noninjected ears. IL-8-
injected ears histologically demonstrated thickening of the epithelial
layer and subepithelial space (SES), with inflammatory cell infiltrat
ion in the SES peaking at 4 to 8 hours and resolving by 48 hours. Bact
eria-injected ears demonstrated findings similar to, although not as e
xtensive as, those found in IL-8-injected ears (i.e., inflammatory rea
ctions peaked at 8 to 24 hours and resolved by 72 hours). Our results
demonstrate that IL-8 is a potent inducer of middle ear inflammation a
nd support the concept that IL-8 may be one of the key cytokines respo
nsible for the leukocyte accumulation and activation seen in otitis me
dia.